Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), announced today that ...

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up ...

Health Education for All: A program featuring expert presentations and interactive learning stations begins on April 14, 2026.

Community Notes FRIDAY Senior Lunch — Dining hall opens at 11 a.m., Bob Chisholm Community Center, 1225 Avenue A, Seaside.

Here's how to keep your knees healthy in the long haul.

The Padma Shri awardee who shunned money and power was found soiled, alone, and barely alive in January. Even as his ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics to modify ...

Study Did Not Meet Primary or Secondary Efficacy Endpoints; Insmed Will Discontinue HS Program- -Safety Was Consistent with Previous Studies and No New Safety Signals ...

Thanks to spending years of her life as a professional racquetball player, Jen Maydas-Dering, 54, had always felt fit and energetic. But a sudden and mysterious health scare left her struggling to ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...